Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05360056 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring Following Hospital Discharge

A NA study of Type 2 Diabetes, sponsored by Kathleen Dungan.

Active
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT05360056: Active NA study of Type 2 Diabetes, sponsored by Kathleen Dungan.

NCT05360056 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by Kathleen Dungan. The registered enrollment target is 108 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05360056, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by Kathleen Dungan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patients will complete surveys assessing patient-reported outcomes prior to CGM use and following completion of the study. CGM data will be captured by the patient smartphone app and analyzed. Patients will receive personalized CGM targets and alerts for hyperglycemia and hypoglycemia. Customized reports/ decision support will be sent to the usual diabetes provider. The initial observational cohort study design will be followed by an extension phase of 12 weeks in which data on continuation of use and glucose control will be collected but no further reports will be communicated to providers.

Conditions Studied

Type 2 Diabetes

Interventions

  • DEVICE DexCom G6

Study Locations (1)

Ohio

  • The Ohio State University Medical Center - Outpatient Care East - Columbus

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2022-04-26
Est. Completion 2025-12
Phase NA

Sponsor

Kathleen Dungan

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05360056

The ClinicalTrials.gov registry entry for NCT05360056 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Kathleen Dungan, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which DexCom G6 is the first listed.

NCT05360056 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05360056 about?

NCT05360056 is a clinical study titled "Continuous Glucose Monitoring Following Hospital Discharge". In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patients will complete surveys assessing patient-reported outcomes prior to CGM use and following completio...

What is the current status of trial NCT05360056?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2022-04-26. Estimated completion is 2025-12.

What conditions does trial NCT05360056 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05360056?

The interventions under investigation include: DexCom G6 (DEVICE).

Who is sponsoring clinical trial NCT05360056?

This trial is sponsored by Kathleen Dungan, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05360056 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.